Cargando…
Metabolic Disorder, Inflammation, and Deregulated Molecular Pathways Converging in Pancreatic Cancer Development: Implications for New Therapeutic Strategies
Pancreatic cancer develops and progresses through complex, cumulative biological processes involving metabolic disorder, local inflammation, and deregulated molecular pathways. The resulting tumor aggressiveness hampers surgical intervention and renders pancreatic cancer resistant to standard chemot...
Autores principales: | Motoo, Yoshiharu, Shimasaki, Takeo, Ishigaki, Yasuhito, Nakajima, Hideo, Kawakami, Kazuyuki, Minamoto, Toshinari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756371/ https://www.ncbi.nlm.nih.gov/pubmed/24212624 http://dx.doi.org/10.3390/cancers3010446 |
Ejemplares similares
-
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer
por: Shimasaki, Takeo, et al.
Publicado: (2012) -
Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
por: Kitano, Ayako, et al.
Publicado: (2013) -
Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro
por: TAKATA, TAKANOBU, et al.
Publicado: (2012) -
Glycogen synthase kinase‐3β is a pivotal mediator of cancer invasion and resistance to therapy
por: Domoto, Takahiro, et al.
Publicado: (2016) -
Thymidylate synthase locus LOH in combination with genotype has prognostic and predictive significance in colorectal cancer
por: Kotake, Masanori, et al.
Publicado: (2021)